Dermatologicals in Russia

September 2021 | 25 pages | ID: D6711EE13FFEN
Euromonitor International Ltd

Abstracts

Haemorrhoid treatments has been one of the most dynamic categories in 2021 in current value terms, although this is partly due to an increase in unit prices. Haemorrhoids is a growing problem among the population in Russia. The main reason for this is a poor diet and a lack of exercise with constipation being the main contributing factor behind haemorrhoids. The outbreak of COVID-19 has seen consumers leading more sedentary lifestyles which is another reason behind the stronger growth being seen...

Euromonitor International's Dermatologicals in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Dermatologicals market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

DERMATOLOGICALS IN RUSSIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Poor diet and lack of exercise continues to drive demand for haemorrhoid treatments
Demand for topical germicidals/antiseptics softens as consumers learn to live with COVID-19
Antipruritics sees strong demand as consumers look to treat COVID-19 rashes
PROSPECTS AND OPPORTUNITIES
E-commerce could support stronger sales of sensitive products over the forecast period
Miramistin and Akriderm expected to remain key drivers of growth in dermatologicals
Easing of COVID-19 restrictions set to benefit dermatologicals
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2016-2021
Table 2 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 4 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 6 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN RUSSIA
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 9 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2016-2021
Table 11 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 12 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 13 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources